Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Aducanumab> ?p ?o }
Showing triples 1 to 40 of
40
with 100 triples per page.
- Aducanumab abstract "Aducanumab is the given USAN and INN name for a biopharmaceutical, the human monoclonal antibody and drug candidate BIIB037 designed for treatment of Alzheimer's disease (AD). It is being developed by Biogen Idec, which licensed the drug candidate from Neurimmune, its discoverer. The antibody targets aggregated forms of beta amyloid. Interim results from the second Phase 1 study of the drug were reported at the 12th International Conference on Alzheimer’s and Parkinsons’s Diseases and Related Neurological Disorders (AD/PD 2015), in Nice, France, in March 2015.".
- Aducanumab atcPrefix "none".
- Aducanumab casNumber "1384260-65-4".
- Aducanumab wikiPageID "41323388".
- Aducanumab wikiPageLength "2349".
- Aducanumab wikiPageOutDegree "9".
- Aducanumab wikiPageRevisionID "707381568".
- Aducanumab wikiPageWikiLink Alzheimers_disease.
- Aducanumab wikiPageWikiLink Amyloid_beta.
- Aducanumab wikiPageWikiLink Biogen.
- Aducanumab wikiPageWikiLink Biopharmaceutical.
- Aducanumab wikiPageWikiLink Category:Monoclonal_antibodies.
- Aducanumab wikiPageWikiLink Drug_development.
- Aducanumab wikiPageWikiLink International_nonproprietary_name.
- Aducanumab wikiPageWikiLink Nice.
- Aducanumab wikiPageWikiLink Union_of_South_American_Nations.
- Aducanumab wikiPageWikiLinkText "Aducanumab".
- Aducanumab atcPrefix "none".
- Aducanumab casNumber "1384260".
- Aducanumab chemspiderid "none".
- Aducanumab molecularWeight "145.9".
- Aducanumab source "u".
- Aducanumab type "mab".
- Aducanumab wikiPageUsesTemplate Template:Drugbox.
- Aducanumab wikiPageUsesTemplate Template:Monoclonals_for_bone,_musculoskeletal,_circulatory,_and_neurologic_systems.
- Aducanumab wikiPageUsesTemplate Template:Reflist.
- Aducanumab subject Category:Monoclonal_antibodies.
- Aducanumab hypernym USAN.
- Aducanumab type ChemicalSubstance.
- Aducanumab type Drug.
- Aducanumab type ChemicalObject.
- Aducanumab type Thing.
- Aducanumab type Q8386.
- Aducanumab comment "Aducanumab is the given USAN and INN name for a biopharmaceutical, the human monoclonal antibody and drug candidate BIIB037 designed for treatment of Alzheimer's disease (AD). It is being developed by Biogen Idec, which licensed the drug candidate from Neurimmune, its discoverer. The antibody targets aggregated forms of beta amyloid.".
- Aducanumab label "Aducanumab".
- Aducanumab sameAs Q15708278.
- Aducanumab sameAs m.0zmzwqq.
- Aducanumab sameAs Q15708278.
- Aducanumab wasDerivedFrom Aducanumab?oldid=707381568.
- Aducanumab isPrimaryTopicOf Aducanumab.